Status:
UNKNOWN
Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Osteoporosis
Eligibility:
MALE
60-90 years
Phase:
NA
Brief Summary
The purpose of this research is to determine whether the prevalence of osteoporosis is greater in patients who suffer from Chronic obstructive pulmonary disease (COPD) or Asthma disease and uses inhal...
Eligibility Criteria
Inclusion
- Man at the minimum age of 60 years.
- Diagnosed with Chronic Obstructive Pulmonary disease (COPD) or Asthma disease.
- Usage of the following corticosteroids at the minimal doses indicated, for at least 3 years:
- Seretide 250/50 mcg Symbicort 320/9 mcg 5.No Diagnosis of thyroid irregularity 6.No diagnosis/treatment for Osteoporosis.
Exclusion
- Usage of systemic steroids more than once during the 12 months prior to the study.
- Usage of systemic steroids during the month prior to the study.
- Usage of inhaled steroids in order to treat any other disease except Chronic Obstructive Pulmonary Disease (COPD) or Asthma.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01246375
Start Date
December 1 2010
End Date
December 1 2011
Last Update
November 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv medical center
Tel Aviv, Israel, Israel